Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of Chindex International Inc. (“Chindex”) (NasdaqGS: CHDX) related to the acquisition by a buyer consortium affiliated with TPG Capital, Shanghai Fosun Pharmaceutical Group Co., Ltd., and Chindex CEO Roberta Lipson for shareholders. Under the terms of the proposed buyout, which is valued at approximately $369 million, Chindex shareholders will only receive $19.50 in cash for each share owned.

If you are an affected investor, and you want to learn more about the lawsuit or join the action, contact Willie Briscoe at The Briscoe Law Firm, PLLC, (214) 239-4568, or via email at, or Patrick Powers at Powers Taylor LLP, toll free (877) 728-9607, via e-mail at There is no cost or fee to you.

The Chindex investigation centers on whether Chindex’s Board of Directors is acting in the shareholders’ best interests, whether the board is properly considering the proposed price for the shareholders, and whether the board has employed an adequate process to review and act on the proposed transaction. “In addition to investigating the fairness of the deal compensation to CHDX shareholders, we are also reviewing whether there are any conflicts of interest related to company insiders being involved in the sale,” said shareholder rights attorney Patrick Powers.

The Briscoe Law Firm, PLLC is a full service business litigation and shareholder rights advocacy firm with more than 20 years of experience in complex litigation and transactional matters.

Powers Taylor LLP is a boutique litigation law firm that handles a variety of complex business litigation matters, including claims of investor and stockholder fraud, shareholder oppression, shareholder derivative suits, and security class actions.

Copyright Business Wire 2010